218 related articles for article (PubMed ID: 38491163)
1. MR-Guided Transurethral Ultrasound Ablation (TULSA)-An Emerging Minimally Invasive Treatment Option for Localised Prostate Cancer.
Fung KFK; Cazzato RL; Tricard T; Marini PDE; Bertucci G; Autrusseau PA; Koch G; Weiss J; Garnon J; Lang H; Gangi A
Cardiovasc Intervent Radiol; 2024 Jun; 47(6):689-701. PubMed ID: 38491163
[TBL] [Abstract][Full Text] [Related]
2. MR-Guided Transurethral Ultrasound Ablation (TULSA): An Emerging Minimally Invasive Treatment Option for Localised Prostate Cancer.
Akhlaghpour S
Cardiovasc Intervent Radiol; 2024 Jun; 47(6):702-704. PubMed ID: 38710796
[No Abstract] [Full Text] [Related]
3. Magnetic Resonance Imaging-Guided Transurethral Ultrasound Ablation of Prostate Tissue in Patients with Localized Prostate Cancer: A Prospective Phase 1 Clinical Trial.
Chin JL; Billia M; Relle J; Roethke MC; Popeneciu IV; Kuru TH; Hatiboglu G; Mueller-Wolf MB; Motsch J; Romagnoli C; Kassam Z; Harle CC; Hafron J; Nandalur KR; Chronik BA; Burtnyk M; Schlemmer HP; Pahernik S
Eur Urol; 2016 Sep; 70(3):447-55. PubMed ID: 26777228
[TBL] [Abstract][Full Text] [Related]
4. Magnetic Resonance Imaging-Guided Transurethral Ultrasound Ablation of Prostate Cancer: A Systematic Review.
Dora C; Clarke GM; Frey G; Sella D
J Endourol; 2022 Jun; 36(6):841-854. PubMed ID: 35029127
[No Abstract] [Full Text] [Related]
5. Twelve-month prostate volume reduction after MRI-guided transurethral ultrasound ablation of the prostate.
Bonekamp D; Wolf MB; Roethke MC; Pahernik S; Hadaschik BA; Hatiboglu G; Kuru TH; Popeneciu IV; Chin JL; Billia M; Relle J; Hafron J; Nandalur KR; Staruch RM; Burtnyk M; Hohenfellner M; Schlemmer HP
Eur Radiol; 2019 Jan; 29(1):299-308. PubMed ID: 29943185
[TBL] [Abstract][Full Text] [Related]
6. Acute and subacute prostate MRI findings after MRI-guided transurethral ultrasound ablation of prostate cancer.
Mäkelä P; Anttinen M; Suomi V; Steiner A; Saunavaara J; Sainio T; Horte A; Taimen P; Boström P; Blanco Sequeiros R
Acta Radiol; 2021 Dec; 62(12):1687-1695. PubMed ID: 33251811
[TBL] [Abstract][Full Text] [Related]
7. Single center retrospective analysis of fifty-two prostate cancer patients with customized MR-guided transurethral ultrasound ablation (TULSA).
Lumiani A; Samun D; Sroka R; Muschter R
Urol Oncol; 2021 Dec; 39(12):830.e9-830.e16. PubMed ID: 34144892
[TBL] [Abstract][Full Text] [Related]
8. Magnetic resonance imaging-guided transurethral ultrasound ablation in patients with localised prostate cancer: 3-year outcomes of a prospective Phase I study.
Nair SM; Hatiboglu G; Relle J; Hetou K; Hafron J; Harle C; Kassam Z; Staruch R; Burtnyk M; Bonekamp D; Schlemmer HP; Roethke MC; Mueller-Wolf M; Pahernik S; Chin JL
BJU Int; 2021 May; 127(5):544-552. PubMed ID: 33037765
[TBL] [Abstract][Full Text] [Related]
9. Magnetic resonance imaging-guided transurethral ultrasound ablation of prostate tissue in patients with localized prostate cancer: single-center evaluation of 6-month treatment safety and functional outcomes of intensified treatment parameters.
Hatiboglu G; Popeneciu V; Bonekamp D; Burtnyk M; Staruch R; Pahernik S; Tosev G; Radtke JP; Motsch J; Schlemmer HP; Hohenfellner M; Nyarangi-Dix JN
World J Urol; 2020 Feb; 38(2):343-350. PubMed ID: 31062122
[TBL] [Abstract][Full Text] [Related]
10. Fiducial markers and their impact on ablation outcome for patients treated with MR-guided transurethral ablation (TULSA): a retrospective technical analysis.
Wright C; Mäkelä P; Anttinen M; Sainio T; Boström PJ; Blanco Sequeiros R
Int J Hyperthermia; 2021; 38(1):1677-1684. PubMed ID: 34927517
[TBL] [Abstract][Full Text] [Related]
11. MR Imaging-Guided Transurethral Ultrasound Ablation of Localized Prostate Cancer: Preliminary Experience from a Single Center in a Prospective, Multi-Center, Single-Arm Clinical Trial.
Sundaram KM; Staruch R; Burtnyk M; Lane JS; Penson DF; Arora SS
J Vasc Interv Radiol; 2020 May; 31(5):740-746.e4. PubMed ID: 32307311
[TBL] [Abstract][Full Text] [Related]
12. Salvage open radical prostatectomy for recurrent prostate cancer following MRI-guided transurethral ultrasound ablation (TULSA) of the prostate: feasibility and efficacy.
Nair SM; Stern N; Dewar M; Siddiqui K; Smith E; Gomez JA; Moussa M; Chin JL
Scand J Urol; 2020 Jun; 54(3):215-219. PubMed ID: 32308085
[No Abstract] [Full Text] [Related]
13. Magnetic Resonance Imaging-Guided Transurethral Ultrasound Ablation of Prostate Cancer.
Klotz L; Pavlovich CP; Chin J; Hatiboglu G; Koch M; Penson D; Raman S; Oto A; Fütterer J; Serrallach M; Relle J; Lotan Y; Heidenreich A; Bonekamp D; Haider M; Tirkes T; Arora S; Macura KJ; Costa DN; Persigehl T; Pantuck AJ; Bomers J; Burtnyk M; Staruch R; Eggener S
J Urol; 2021 Mar; 205(3):769-779. PubMed ID: 33021440
[TBL] [Abstract][Full Text] [Related]
14. MR-Guided High-Intensity Directional Ultrasound Ablation of Prostate Cancer.
Galgano SJ; Planz VB; Arora S; Rais-Bahrami S
Curr Urol Rep; 2021 Jan; 22(1):3. PubMed ID: 33403460
[TBL] [Abstract][Full Text] [Related]
15. Relief of Lower Urinary Tract Symptoms After MRI-Guided Transurethral Ultrasound Ablation for Localized Prostate Cancer: Subgroup Analyses in Patients with Concurrent Cancer and Benign Prostatic Hyperplasia.
Elterman D; Li W; Hatiboglu G; Relle J; Zorn KC; Bhojani N; Chin J
J Endourol; 2021 Apr; 35(4):497-505. PubMed ID: 32935575
[No Abstract] [Full Text] [Related]
16. Magnetic resonance imaging-guided transurethral ultrasound ablation for benign prostatic hyperplasia: 12-month clinical outcomes of a phase I study.
Viitala A; Anttinen M; Wright C; Virtanen I; Mäkelä P; Hovinen T; Sainio T; Saunavaara J; Taimen P; Blanco Sequeiros R; Boström PJ
BJU Int; 2022 Feb; 129(2):208-216. PubMed ID: 34161649
[TBL] [Abstract][Full Text] [Related]
17. Evaluation of Focal Ablation of Magnetic Resonance Imaging Defined Prostate Cancer Using Magnetic Resonance Imaging Controlled Transurethral Ultrasound Therapy with Prostatectomy as the Reference Standard.
Ramsay E; Mougenot C; Staruch R; Boyes A; Kazem M; Bronskill M; Foster H; Sugar L; Haider M; Klotz L; Chopra R
J Urol; 2017 Jan; 197(1):255-261. PubMed ID: 27545572
[TBL] [Abstract][Full Text] [Related]
18. Urinary Outcomes After Magnetic Resonance Imaging-Guided Whole-Gland Transurethral Ultrasound Ablation for Prostate Cancer: Comparison of Suprapubic Tube to Indwelling Urethral Catheter.
Rabinowitz MJ; Haney NM; Myers AA; Dora CD; Pavlovich CP
J Endourol; 2023 Jan; 37(1):1-7. PubMed ID: 36017622
[No Abstract] [Full Text] [Related]
19. Magnetic Resonance-Guided High-Intensity Focused Ultrasound (MR-HIFU): Overview of Emerging Applications (Part 2).
Siedek F; Yeo SY; Heijman E; Grinstein O; Bratke G; Heneweer C; Puesken M; Persigehl T; Maintz D; Grüll H
Rofo; 2019 Jun; 191(6):531-539. PubMed ID: 30630199
[TBL] [Abstract][Full Text] [Related]
20. MR Imaging-Guided Prostate Cancer Therapies.
Adamo DA; Greenwood BM; Ghanouni P; Arora S
Radiol Clin North Am; 2024 Jan; 62(1):121-133. PubMed ID: 37973238
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]